Palm Beach and West Palm Beach, Florida
Exosome supply and 503A pharmacy access for Palm Beach and West Palm Beach
ExaVeyra supplies research-use exosome material to licensed practices on Palm Beach island and in West Palm Beach from its base in Miami Beach, and because Florida is a state where the 503A pharmacy partner holds a non-resident license, a prescriber here can also send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly. This page covers what a practice here can source, how material arrives, and where the Florida law questions are answered.
It speaks to the practice, names no condition or use, and leaves delegation and statute to the Florida sourcing guide.
What a Palm Beach and West Palm Beach practice can source
| Material | Availability here |
|---|---|
| Exosome material | Available. Research-use exosome formats, characterised per lot, shipped cold-chain from Miami Beach to licensed practices in every state and Puerto Rico. |
| Compounded 503A preparations | Available. Prepared to an individual prescription by our 503A pharmacy partner, which holds a non-resident pharmacy license for Florida, and dispensed by that pharmacy to the patient named on the prescription. |
| Documentation | A lot-specific certificate of analysis is available on request for every exosome lot; compounded preparations carry the pharmacy label and beyond-use date. |
The practice landscape in Palm Beach and West Palm Beach
The town of Palm Beach is a barrier island with a small year-round population and a large seasonal one, and its practice base reflects that: concierge and membership-model internal medicine, dermatology and aesthetic practices on and around Royal Poinciana Way and South County Road, and a private-practice population that follows its residents between here and the northeast from late autumn through spring. Across the Intracoastal, West Palm Beach carries the clinical weight of the county, with Good Samaritan Medical Center and St. Mary's Medical Center, and the medical office corridor along Flagler Drive and the Palm Beach Lakes Boulevard district.
West Palm Beach has also drawn a wave of financial-services relocations to its downtown in recent years, and the concierge, longevity and aesthetic practices that serve that population have followed them into the Clematis and Rosemary Square districts. Jupiter and Palm Beach Gardens to the north, with the Jupiter Medical Center campus and the PGA Boulevard office corridor, are served on the same lane. The state sourcing guide lists West Palm Beach among the Florida metros ExaVeyra supplies.
On the island the added consideration is the season itself: a number of practices reduce their hours or close for the summer, and a shipment placed against the off-season calendar can arrive at a closed suite. The account records the months the practice is staffed and the person who signs during them, and the ExaVeyra team checks the dispatch day against that record. In West Palm Beach the medical office corridor runs year-round staffed receiving desks, so a weekday delivery there is routine, and the bridges into the town add minutes rather than a day.
Across the county the practice pattern splits by district. Wellington and the western communities carry an equestrian population and sports medicine and orthopaedic groups that serve it, Boynton Beach and Delray Beach to the south carry a retiree and seasonal population with a concierge base, and the Northwood and Flagler corridors in West Palm Beach carry the hospital-affiliated specialists. Each district orders on its own calendar, and the account records the address and the staff member who signs so that a lot is traceable to the site that received it.
The hair and scalp literature, for Palm Beach and West Palm Beach practices
The hair and scalp series on this site sets out, component by component, what the peer-reviewed literature and the FDA say about each formulation class the literature discusses. What follows is what that means for sourcing in this market.
The hair and scalp series on this site is the evidence reference for each formulation class the literature discusses, and for a Palm Beach County practice the sourcing position is that research-use exosome formats are supplied on the practice's verified account, and the compounded preparations the pharmacy partner prepares are dispensed by that pharmacy against individual prescriptions, so the two travel separately under their own regimes. The evidence pages set out the literature and the FDA communications for each component, and the product category lists what the pharmacy partner prepares to prescription.
A seasonal practice that sees its patients here for part of the year and elsewhere for the rest tends to ask how a compounded preparation follows the patient. It does not follow the practice; whether a prescription is valid for a patient in another state, and which licence the prescriber needs to write it, are questions for the pharmacy partner and the two states' boards rather than for a supplier. The Florida guide links the Florida boards.
How material reaches Palm Beach and West Palm Beach
Cold-chain shipments dispatch from the Miami Beach facility under continuous temperature monitoring and reach Florida practices in 1 to 3 business days, scheduled to avoid a weekend hold at the carrier hub.
Florida destinations sit on the shortest lane ExaVeyra runs, and cold-chain shipping is free to Florida destinations from 6 units against 15 units nationwide; the threshold is applied by the cart rather than quoted case by case.
Florida law is a separate question, answered in the state guide
What a Florida practice may offer, who in the practice may handle material, whether the state has a stem cell or regenerative-medicine statute and how any such statute reads against an acellular preparation, and which boards verify a license are covered in the Florida sourcing guide rather than repeated here. Nothing about the city changes any of it.
Palm Beach and West Palm Beach sourcing questions
- How does material reach a practice on Palm Beach island?
- Shipments dispatch from the Miami Beach facility under validated temperature monitoring and travel the Florida lane by carrier to the address on file, over one of the bridges from West Palm Beach. Palm Beach County is a Florida destination, so the fulfilment window and free cold-chain threshold the Miami page describes apply, and delivery is by carrier rather than local courier. The receiving checks on the cold-chain page apply on arrival, and a practice in a building with a seasonal front desk should name who signs for the package.
- Can a Palm Beach practice source both exosome material and compounded preparations?
- Yes. Florida is a state where the 503A pharmacy partner holds a non-resident pharmacy license, so a prescriber in Palm Beach County can send an individual prescription for a compounded preparation to that pharmacy, which dispenses it directly, and research-use exosome material ships to an island address on the practice's verified account. The two are handled under separate regimes and never share a shipment or a stocking calendar.
- Are Jupiter and Palm Beach Gardens served the same way as West Palm Beach?
- Yes. Each is a Palm Beach County address on the same Florida lane, with the same compounding availability and the same account structure, and a group with locations up and down the county can list each delivery address on one account so lots trace to the site that received them.
Sources
- Florida Department of Health (accessed 15 September 2026)
- Florida Board of Medicine (accessed 15 September 2026)
- Florida Board of Pharmacy (accessed 15 September 2026)
Last reviewed 17 September 2026 by Benn Bluestein-Veyra, M.Sc. Organic Chemistry. Availability is read from the state registry at the time of the request.
These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. There are no FDA-approved exosome products. Exosome material distributed by ExaVeyra Sciences is supplied for Research Use Only, for medical, molecular biology, and biochemistry research applications, and ExaVeyra Sciences makes no statement about administration, route, or outcome. Compounded medications are a separate product class: they are not FDA-approved finished drug products, they are prepared under section 503A of the Federal Food, Drug, and Cosmetic Act against a prescription for an individual patient, and they are prescription products rather than research-use-only material. ExaVeyra does not supply controlled substances. This page is provided for informational purposes only. It is not medical advice, it is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for the judgment of a licensed practitioner. Consult a healthcare professional before acting on anything stated here. The FDA has not approved GHK-Cu or any exosome product for hair loss or any form of alopecia. Compounded medications are not FDA-approved; they are prepared by a licensed 503A compounding pharmacy for an individual patient against that patient’s prescription, and they are supplied to NPI-verified licensed practitioners only. Where this page discusses an FDA-approved active such as oral finasteride or topical minoxidil, the approved product’s labeling governs and nothing here modifies it. ExaVeyra Sciences is a supplier and takes no part in any diagnosis, treatment decision, or plan of care. ExaVeyra Sciences does not supply controlled substances. Findings described on this page are attributed to the peer-reviewed literature and to the agencies cited, and a citation establishes that a question was studied, not that any product is suitable for a given patient. The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here. Exosome material is supplied for Research Use Only. No exosome product is FDA-approved for any use, and ExaVeyra Sciences makes no statement about administration, route, or outcome.
Reference only. Not legal or medical advice.
The content of these guides is provided for general informational purposes only. It does not constitute legal, medical, or regulatory advice, and does not establish that any particular product or practice is compliant. Regulatory requirements vary by state and depend on the circumstances of each practice. Each practitioner should consult their own legal counsel and the applicable state licensing boards before acting on anything stated here.
Read the full disclaimer
ExaVeyra Sciences publishes these guides as a reference for licensed practitioners. They summarize publicly available federal and state requirements as those requirements read on the review date shown above. The content is provided for general informational purposes only and does not constitute legal, medical, or regulatory advice, and it does not establish that any particular product or practice is compliant.
No attorney-client relationship, and no professional or clinical relationship of any kind, is created by accessing these materials. ExaVeyra Sciences is a supplier of research-use materials. It is not a law firm, it is not a regulatory consultant, and it takes no part in any diagnosis, treatment decision, or plan of care. Each practitioner is responsible for retaining their own legal counsel and for determining, with that counsel and the applicable state licensing boards, how the requirements described here apply to the services, staffing, and structure of their own practice.
Statutes, regulations, board rules, and agency positions are subject to amendment, supersession, and reinterpretation. ExaVeyra Sciences makes no representation or warranty as to the accuracy, completeness, timeliness, or applicability of this content to any particular practice. Citations and links to third-party sources are provided for convenience only and do not constitute an endorsement of their content.
The practitioner and the practice are solely responsible for compliance with all applicable licensing, scope of practice, supervision, ownership, facility, recordkeeping, and tax requirements, and for all clinical decisions, including the suitability of any material for a given patient. To the fullest extent permitted by law, ExaVeyra Sciences disclaims all liability for any action taken or not taken in reliance on this content.